Published in Immunology on April 01, 1991
Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect Immun (1994) 1.57
Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol (1991) 1.12
Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg). Clin Exp Immunol (1993) 1.01
Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology (1995) 0.95
Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin. Clin Exp Immunol (1994) 0.82
In vitro effects of polyvalent immunoglobulin for intravenous use. J Neurol Neurosurg Psychiatry (1994) 0.81
Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.80
Suppressive effects of co-stimulatory molecule expressions on mouse splenocytes by anti-allergic agents in vitro. Mediators Inflamm (2000) 0.80
The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids. J Clin Immunol (1997) 0.78
Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro. Mediators Inflamm (2001) 0.77
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry (1984) 10.83
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem (1988) 4.44
Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods (1984) 4.27
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun (1988) 3.63
Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol (1986) 2.68
Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol (1988) 2.58
Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol (1986) 2.37
Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun (1986) 1.95
Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol (1987) 1.73
Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes. Immunology (1989) 1.60
Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP. Immunology (1988) 1.42
Regulation of interleukin 1 production by mouse peritoneal macrophages. Effects of arachidonic acid metabolites, cyclic nucleotides, and interferons. J Biol Chem (1986) 1.30
Release of cyclic AMP from macrophages by stimulation with prostaglandins. J Immunol (1975) 1.06
Biological activities residing in the Fc region of immunoglobulin. Adv Immunol (1987) 0.96
Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits. Infect Immun (1987) 0.95
Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1. Cancer Res (1987) 0.90
Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use. Infect Immun (1990) 0.88
[Therapeutic evaluation of combination therapy with IG-100, pH4-treated human immunoglobulin preparation for i.v. administration, and antibiotics against severe infections. The Society for Clinical Investigation on IG-100]. Kansenshogaku Zasshi (1984) 0.86
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry (1966) 15.12
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol (1998) 11.26
Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science (1998) 6.53
Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum. J Immunol (1967) 3.86
Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet (1996) 2.47
The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity (1998) 2.23
Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol Cell Biol (2001) 2.18
Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A (2001) 1.99
Studies on orally active cephalosporin esters. J Antibiot (Tokyo) (1987) 1.72
The purification and reactivity of the first component of complement from guinea pig, human and canine sera. J Immunol (1968) 1.71
Tricorn protease--the core of a modular proteolytic system. Science (1996) 1.71
Comparison of changes in jugular venous bulb oxygen saturation and cerebral oxygen saturation during variations of haemoglobin concentration under propofol and sevoflurane anaesthesia. Br J Anaesth (2004) 1.69
Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation (1998) 1.69
Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest (1994) 1.60
Preservation of a certain motoneurone group of the sacral cord in amyotrophic lateral sclerosis: its clinical significance. J Neurol Neurosurg Psychiatry (1977) 1.59
Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes (1995) 1.58
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J Exp Med (1987) 1.55
Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J Biol Chem (1998) 1.54
Expression of a Maize Ubiquitin Gene Promoter-bar Chimeric Gene in Transgenic Rice Plants. Plant Physiol (1992) 1.47
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways. Endocrinology (2000) 1.45
An incompatibility in the reaction of the second component of human complement with the fourth component of guinea-pig complement. Immunology (1970) 1.44
Daily morning hemifacial spasm in a patient with cluster headache. Cephalalgia (2006) 1.44
Atypical Fabry's disease presenting with cholesterol crystal embolization. Intern Med (2000) 1.43
Simultaneous recording of pattern reversal electroretinograms and visual evoked potentials in migraine. Cephalalgia (1997) 1.41
Autologous bone marrow transplantation in children with advanced neuroblastoma. Cancer (1994) 1.39
Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med (1990) 1.37
Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain. J Biol Chem (1995) 1.37
Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci U S A (1998) 1.34
Utilization of bloodfed females of Aedes aegypti as a vehicle for the transfer of the insect growth regulator pyriproxyfen to larval habitats. J Am Mosq Control Assoc (1994) 1.34
Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut (2005) 1.33
The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest (1999) 1.33
Aortoesophageal fistula-relief of massive hematemesis with an endovascular stent-graft. Eur J Radiol (2000) 1.30
Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology (1996) 1.28
Evaluation of new medium with chromogenic substrates for members of the family Enterobacteriaceae in urine samples. J Clin Microbiol (1995) 1.27
Molecular cloning of rat leptin receptor isoform complementary DNAs--identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun (1996) 1.27
Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. Biochem Biophys Res Commun (1999) 1.27
Atypical form of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1999) 1.25
Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother (1993) 1.25
Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. Blood (1999) 1.21
Mid-brain pathology of Wilson's disease: MRI analysis of three cases. J Neurol Neurosurg Psychiatry (1991) 1.21
The ninth component of guinea-pig complement. Isolation and identification as an alpha 2-globulin. Immunology (1971) 1.21
Idiopathic pure sudomotor failure: anhidrosis due to deficits in cholinergic transmission. Neurology (2004) 1.21
Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet (1998) 1.20
Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates. J Immunol (1984) 1.20
Cloning and characterization of a probenazole-inducible gene for an intracellular pathogenesis-related protein in rice. Plant Cell Physiol (1996) 1.20
A nationwide survey on organic solvent components in various solvent products: Part 1. Homogeneous products such as thinners, degreasers and reagents. Ind Health (1983) 1.18
Isolation and characterization of CA XIV, a novel membrane-bound carbonic anhydrase from mouse kidney. J Biol Chem (1999) 1.18
Solubilization of immune precipitates by six isolated alternative pathway proteins. J Exp Med (1981) 1.18
Structures of F420H2:NADP+ oxidoreductase with and without its substrates bound. EMBO J (2001) 1.17
Characterization of three monoclonal antibodies against C3 with selective specificities. Immunology (1987) 1.17
Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest (1995) 1.15
Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin. Biochem Biophys Res Commun (1982) 1.15
Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect Immun (1990) 1.14
Optically active antifungal azoles. VI. Synthesis and antifungal activity of N-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazo l-1- yl)propyl]-N'-(4-substituted phenyl)-3(2H,4H)-1,2,4-triazolones and 5(1H,4H)-tetrazolones. Chem Pharm Bull (Tokyo) (1996) 1.14
Further evidence for immune cytolysis by antibody and the first eight components of complement in the absence of C9. Immunology (1972) 1.12
Neural mechanism of reading and writing in the Japanese language. Funct Neurol (1987) 1.12
A study on biological monitoring of n-hexane exposure. Int Arch Occup Environ Health (1983) 1.10
Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem (1992) 1.09
Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol (1995) 1.08
Complement-mediated solubilization of immune complexes in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.08
Observation of long-distance radial correlation in toroidal plasma turbulence. Phys Rev Lett (2011) 1.08
Hypogenesis of right hepatic lobe accompanied by portal hypertension: case report and review of 31 Japanese cases. J Gastroenterol (1997) 1.08
The Onuf's nucleus and the external anal sphincter muscles in amyotrophic lateral sclerosis and Shy-Drager syndrome. Acta Neuropathol (1982) 1.08
A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks. J Immunol (1989) 1.07
The SV2 protein of synaptic vesicles is a keratan sulfate proteoglycan. J Neurochem (1993) 1.06
Regulation of T lymphocyte apoptosis. Signals for the antagonism between activation- and glucocorticoid-induced death. J Immunol (1991) 1.06
Extended mapping and exploration of the vanadium dioxide stress-temperature phase diagram. Nano Lett (2010) 1.06
Observation of reduced heat transport inside the magnetic island O point in the large helical device. Phys Rev Lett (2004) 1.06
Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol (1999) 1.06
A case of plasmacytosis with multiple peculiar eruptions. J Dermatol (1980) 1.05
Development of a time-resolved fluoroimmunoassay (TR-FIA) for testosterone: measurement of serum testosterone concentrations after testosterone treatment in the rainbow trout (Oncorhynchus mykiss). Gen Comp Endocrinol (1997) 1.05
Study of bronchus-associated lymphoid tissue in patients with diffuse panbronchiolitis. Am Rev Respir Dis (1992) 1.04
Development of bronchus-associated lymphoid tissue in chronic hypersensitivity pneumonitis. Chest (1999) 1.04
Kinetics of lymphocyte stimulation by concanavalin A. Nature (1976) 1.04
Degeneration of the cerebellar system in X-chromosome-linked copper malabsorption. Ann Neurol (1979) 1.04
Cysteine-scanning mutagenesis of transmembrane segments 4 and 5 of the Tn10-encoded metal-tetracycline/H+ antiporter reveals a permeability barrier in the middle of a transmembrane water-filled channel. J Biol Chem (2000) 1.03
Unilateral palatal paralysis caused by lesion in the corticobulbar tract. Arch Neurol (1984) 1.03
Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (1998) 1.03
Serum cardiac troponin T in polymyositis/dermatomyositis. Lancet (1992) 1.03
Role of lipomodulin, a phospholipase inhibitory protein, in immunoregulation by thymocytes. J Immunol (1983) 1.02
Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension (1997) 1.01
Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b. J Exp Med (1983) 1.01
iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci Lett (2000) 1.00
Structural organization and chromosomal assignment of the human obese gene. J Biol Chem (1995) 1.00
Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome. Biochim Biophys Acta (1995) 1.00
Involvement of heat shock protein 90 in the degradation of mutant insulin receptors by the proteasome. J Biol Chem (1998) 0.99
Characterization of the 5'-flanking region and chromosomal assignment of the human brain natriuretic peptide gene. J Mol Med (Berl) (1995) 0.99
A case of right atrial myxoma--effect of large myxoma in the right atrium studied by M-mode and Doppler echocardiography. Jpn Circ J (1995) 0.99
Neurotoxicity of petroleum benzine compared with n-hexane. Int Arch Occup Environ Health (1982) 0.98
[Increased CA19-9 level in serum and bronchoalveolar lavage fluid from a patient with pulmonary tuberculosis]. Nihon Kyobu Shikkan Gakkai Zasshi (1996) 0.98
Inorganic fluoride. Divergent effects on human proximal tubular cell viability. Am J Pathol (1997) 0.98
Calcineurin activation protects T cells from glucocorticoid-induced apoptosis. J Immunol (1995) 0.98
Different cortical activity in reading of Kanji words, Kana words and Kana nonwords. Brain Res Cogn Brain Res (2000) 0.97
Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med (1996) 0.97
Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3). Genomics (1997) 0.97
Post-ischemic acute renal failure protects proximal tubules from O2 deprivation injury, possibly by inducing uremia. Kidney Int (1994) 0.97
Suppression of motor cortical excitability by electrical stimulation over the cerebellum in ataxia. Ann Neurol (1994) 0.97